TGA News: TGA Extends Fee-Free Period for Permissible Indications Transition

By avicennaco | Sep 19, 2019

The TGA has extended the fee-free period for sponsors of existing listed medicines to transition to using permitted indications until 6 March 2021

Read More

TGA News: Consultation on Changes to the Permissible Ingredients Determination

By avicennaco | Sep 9, 2019

The TGA is consulting on changes to the permissible ingredients determination. Submissions are due on 11 October 2019.

Read More

TGA News: Advertising Requirements Decision Tree

By avicennaco | Aug 29, 2019

The TGA has created a decision tree to help you ensure compliance with the Therapeutic Goods Advertising Code.

Read More

TGA News: Updates to the Permissible Indications Determination

By avicennaco | Aug 23, 2019

The Permissible Indications Determination will be updated this month with four new indications and 32 changes to existing entries.

Read More

Science News: Increasing Father’s Folate Intake for Healthier Babies?

By avicennaco | Aug 20, 2019

New research suggests that a father’s preconception folate intake can be important for a baby’s health.

Read More

TGA News: Sunscreen advice

By avicennaco | Aug 13, 2019

The TGA has issued on what to look for when choosing a sunscreen, and steps that can be taken to…

Read More

ARCS Annual Conference 2019

By avicennaco | Aug 13, 2019

We attended the ARCS Annual Conference 2019 as exhibitors and had a wonderful time!

Read More

TGA News: $10 Million Penalty for Advertising Breaches

By avicennaco | Jul 25, 2019

The TGA hast just issued a $10 million fine for advertising breaches after the first court action in almost a decade.

Read More

Submission: Medical Board of Australia consultation on complementary medicines

By avicennaco | May 22, 2019

Read our submission to the Medical Board of Australia consultation on complementary medicines

Read More